Back to Blog
Education / Neurology HBOT-Series · Post 4 of 10

HBOT for Stroke and Neurological Recovery: What Patients and Families Need to Know

June 15, 2026 · RxAir360 Editorial Team

800,000

Americans have a stroke every year

7M+

Americans living with lasting stroke-related disability

11K+

monthly searches for HBOT and stroke recovery

Every 40 seconds, someone in the United States has a stroke. Every 3.5 minutes, one of them dies. For the millions who survive, the road ahead is defined by rehabilitation — physical therapy, occupational therapy, speech therapy, and the long work of rewiring a brain that has been fundamentally disrupted. Standard recovery has real limits. And for many patients and families, those limits feel like a ceiling that conventional medicine cannot push through.

Hyperbaric oxygen therapy is drawing increasing attention in neurological medicine precisely because it addresses what standard rehabilitation cannot — the underlying oxygen deprivation and cellular damage that sustains neurological deficits long after the initial event. This post explains what HBOT does for the brain, what conditions it is being studied for, and how to approach the conversation with your physician.

How Stroke Damages the Brain — and Why Standard Recovery Has Limits

A stroke occurs when blood supply to part of the brain is suddenly cut off — either by a clot blocking an artery (ischemic stroke, accounting for 87% of cases) or a blood vessel rupturing (hemorrhagic stroke). Within minutes, brain cells in the affected area begin to die from oxygen starvation.

The immediate damage defines the initial deficit — weakness on one side of the body, speech impairment, vision loss, memory disruption. But the story does not end there. Surrounding the zone of dead tissue is a larger area called the ischemic penumbra — cells that are damaged and functionally silent, but not yet dead. These cells are alive, metabolically struggling, and potentially recoverable. This is the target that HBOT research has focused on most intensively.

Standard rehabilitation — physical therapy, occupational therapy, speech therapy — works by stimulating the brain's natural neuroplasticity: its ability to form new pathways around damaged areas. This is powerful but slow, and it depends entirely on the brain having adequate oxygen and blood supply to support that rewiring. When circulation to affected areas remains compromised, neuroplasticity is limited.

HBOT works at a different level. By delivering hyperoxygenated blood plasma to areas of compromised circulation, it may reactivate dormant cells in the penumbra, reduce neuroinflammation that impedes recovery, and create the biological conditions that allow rehabilitation to work more effectively.

How HBOT Promotes Neuroplasticity and Brain Repair

The mechanisms through which HBOT supports neurological recovery are increasingly well understood. Research has identified several key pathways:

  • •Penumbra reactivation — oxygen delivery to metabolically impaired but viable cells surrounding the zone of infarction, potentially restoring function in tissue that standard imaging would classify as damaged
  • •Neuroinflammation reduction — lowering the chronic inflammatory response that persists after stroke and continues to damage brain tissue for weeks and months
  • •Angiogenesis — stimulating the growth of new blood vessels into oxygen-deprived regions, restoring the circulation that neuroplasticity depends on
  • •Neurogenesis — evidence suggesting HBOT promotes the growth of new neural tissue, particularly relevant in areas of the brain that retain this capacity
  • •Stem cell mobilization — HBOT has been shown to increase circulating stem cells eightfold, with those cells migrating preferentially to sites of brain injury
  • •Gene expression modulation — affecting thousands of genes involved in repair, inflammation, and oxygen metabolism simultaneously

Taken together, these mechanisms explain why HBOT is being studied not just for stroke but across a broad range of neurological conditions where oxygen deprivation, inflammation, and impaired circulation play a central role.

Neurological Conditions HBOT Is Being Studied For

Stroke Recovery

Reactivating penumbral tissue, reducing neuroinflammation, supporting rehabilitation outcomes in ischemic and hemorrhagic stroke survivors.

Traumatic Brain Injury

Addressing chronic post-concussion syndrome, blast-induced TBI in veterans, and acute traumatic brain injury — one of the most active areas of HBOT research.

Parkinson's Disease

Early research suggests HBOT may reduce neuroinflammation and support dopaminergic function, with ongoing studies examining symptom management.

Alzheimer's & Dementia

Studies examining HBOT's effect on amyloid plaque accumulation, cerebral blood flow, and cognitive function in early to moderate Alzheimer's disease.

Cerebral Palsy

Research in pediatric populations showing improvements in motor function, cognitive performance, and quality of life measures following HBOT protocols.

Multiple Sclerosis

Ongoing research into HBOT as a supportive therapy for MS, with some studies showing improvements in fatigue, bladder function, and general well-being.

Important notice

With the exception of specific FDA-cleared indications, the conditions listed above represent active areas of clinical research — not established, cleared treatments. HBOT is not FDA-cleared for stroke recovery, Parkinson's disease, Alzheimer's disease, cerebral palsy, or multiple sclerosis. Patients and families should discuss HBOT with a qualified neurologist or physician before pursuing treatment for any of these conditions.

What the Research Says About HBOT and Stroke Recovery

Stroke Recovery — Peer-Reviewed Evidence

A landmark study published in PLOS ONE examined 74 stroke patients who received HBOT treatment an average of 3.3 years after their strokes — well beyond the conventional rehabilitation window. After 40 HBOT sessions, patients showed significant improvements in neurological function, quality of life, and performance on cognitive assessments. Brain imaging confirmed increased metabolic activity in previously dormant regions. The researchers concluded that HBOT can induce neuroplasticity even in the chronic phase of stroke — a finding that challenges the conventional wisdom that recovery potential diminishes rapidly after the first few months.

Neurological Imaging Evidence

Multiple studies using SPECT and fMRI imaging have documented measurable increases in cerebral blood flow and metabolic activity in brain regions following HBOT. These objective imaging findings correlate with the functional improvements patients report — providing biological confirmation that HBOT is producing real neurological changes, not placebo effects.

How to Talk to Your Doctor About HBOT for Neurological Recovery

Navigating HBOT as a neurological recovery option requires a direct, informed conversation with your physician or neurologist. Here is how to approach it effectively.

Be specific about what you are asking. Do not ask "should I try HBOT?" Ask: "I have read peer-reviewed research suggesting HBOT may support neuroplasticity and cerebral blood flow recovery following ischemic stroke. Can we discuss whether this is appropriate for my situation and what a referral process would look like?"

Bring the research. Print the key studies — the PLOS ONE stroke study and any condition-specific research relevant to your situation. Physicians respond better to evidence-based requests than to information gathered from non-medical sources. Showing you have done the work signals you are a serious, informed patient.

Ask about timing. Research suggests HBOT may produce meaningful results even years after the initial neurological event — challenging the assumption that recovery windows are fixed. Ask your physician about the evidence for late-phase HBOT intervention specifically.

Understand the limitations. HBOT is not a guaranteed treatment for neurological conditions outside its FDA-cleared indications. Recovery outcomes vary significantly between patients. A physician who presents realistic expectations — including the possibility that response may be limited — is a physician worth trusting.

Frequently Asked Questions

How soon after a stroke can HBOT begin?

This is an individual clinical decision. Some research suggests early intervention — within weeks of the stroke — may optimize outcomes by targeting penumbral tissue before it fully dies. Other research has documented meaningful improvements in patients treated years after their initial stroke. Timing should be determined by your neurologist based on your specific case, imaging findings, and overall health status.

How many HBOT sessions are needed for neurological recovery?

Clinical protocols for neurological indications typically involve 40 to 80 sessions, delivered daily or five days per week. The PLOS ONE stroke study used 40 sessions over two months. The right protocol depends on the condition, severity, and individual response to treatment. Your physician will define and adjust the protocol based on your progress.

Is HBOT covered by insurance for stroke or neurological conditions?

Insurance coverage for HBOT is currently limited to its 14 FDA-cleared indications. Stroke recovery, Parkinson's disease, Alzheimer's disease, and most other neurological indications are not among those cleared uses, meaning insurance coverage for these conditions is not standard. Some patients access HBOT through clinical trials, which may provide treatment at no cost. Discuss options with your physician and insurance provider.

Can HBOT help someone who had a stroke years ago?

Yes — research has documented neurological improvements in patients treated years and even decades after their initial stroke. The existence of metabolically impaired but viable brain tissue does not appear to have a strict time limit. This is one of the most significant and counterintuitive findings in HBOT neurology research.

Where can I find a physician who offers HBOT for neurological recovery?

Hyperbaric medicine is typically offered through hospital-based hyperbaric centers, specialized hyperbaric clinics, and increasingly through physician offices. RxAir360 is working to expand HBOT access into physician office settings through our patented monoplace chamber — making it possible for neurologists and rehabilitation physicians to offer HBOT directly within their practices. Contact RxAir360 at rxair360inc.com/contact for more information.

Understanding Hyperbaric Oxygen Therapy — Series

Previous: HBOT for Athletes Post 4 of 10 Next post coming soon

Explore HBOT for your practice or your recovery

RxAir360 is developing the first physician-office monoplace hyperbaric chamber — bringing HBOT closer to neurological patients who need it. Physicians can learn about the platform. Patients can explore HBOT benefits and connect with knowledgeable providers.

For Physicians For Patients & Families

About RxAir360

RxAir360 Inc. is a Bellaire, Texas (Houston area) medical device company developing a patented vertical monoplace hyperbaric oxygen therapy chamber designed for physician offices and neurological recovery centers. Manufactured by Electroimpact — precision engineering partners for Boeing and Airbus — the RxAir360 chamber is pending FDA 510(k) clearance. The company's CARE nonprofit arm supports expanded HBOT access for uninsured and underinsured children.

RxAir360 manufactures the chamber; all clinical protocols and patient treatment decisions are determined exclusively by the licensed physician overseeing care.

rxair360inc.com 5555 W Loop South, Suite 150, Bellaire TX 77401 (240) 640-4560